Certara Products - Simcyp Archives

On-Demand Webinar

Simcyp® Simulator Version 25: Streamline Drug Development with Regulatory-Compliant PBPK

JTVCdGVhbV9tZW1iZXJzJTVESenior Principal ScientistAssociate Principal ScientistPrincipal ScientistSenior Research ScientistDiscover real-world success stories where sponsors leveraged Simcyp…

Certara2026 年 2 月 12 日

Certara Products – Simcyp

Certara Expands Simcyp® Simulator to Streamline Regulatory Submissions and Internal Efficiencies

什么是 Simcyp Discovery 及其如何支持药物发现？

Certara Simcyp® Simulator 成果成功替代慢性髓性白血病（CML）药物 asciminib 的 10 项人体试验

Marbach DDI Workshop 2026

Maximizing the Impact of Antibody–Drug Conjugates (ADCs): Model-Informed Labeling, Expansion, and Market Access

Optimal Dosing, Optimal Outcomes: Model-Based Approaches for Antibody–Drug Conjugates (ADCs)

Strong starts, confident finishes: Optimizing first-in-human strategies for antibody–drug conjugates (ADCs)

ICH M15 Guideline: What the Finalized Guideline Means for Model-Informed Drug Development

Simcyp® Simulator Version 25: Streamline Drug Development with Regulatory-Compliant PBPK

充分发挥 PBPK 模型的全部潜力以加速药物研发

订阅时事通讯

快捷链接

解决方案

联系我们